Adoptive cellular immunotherpy using CD4+, CD8+ T cells specific for N-terminal truncated WT1 and specific monitoring assay in human

摘要

the present invention is an N- terminal truncated WT1 (Wilm's tumor protein, WT1), including the WT1 recombinant adenovirus , said recombinant adenovirus with a transition dendritic cells , and dendritic cells stimulate T cells in the method for producing a specific T cell WT1 that , the composition for treating tumor -specific T cells containing the WT1 and the WT1 specific T cells are related to a method of verifying the treatment efficacy by detecting specific T cell WT1 be implanted in women .